LinkedIn automations are now retired. TexAu V3 is on the way, be the first to know when it launches.

Get updates

How Much Did Olive Raise? Headquarters, Funding & Key Investors

Olive has raised $902 million across multiple rounds, including a landmark $400M Series H in July 2021 at a $4B valuation. Earlier, the company secured $226 million in Series G funding (2020) at a $1.5 billion valuation and $106 million in Series F, bringing its total capital above $700 million within one year. Backed by Tiger Global, Dragoneer, Vista Equity, and General Catalyst, Olive rapidly scaled its AI automation platform for healthcare administration. Founded in 2012, the company achieved unicorn status within 8 years and 11 months, becoming one of the fastest-scaling AI startups in healthcare IT.

    Olive builds AI-driven automation tools for healthcare organizations, helping reduce administrative errors, eliminate manual workflows, and improve operational efficiency. Its platform automates tasks such as eligibility checks, prior authorizations, unadjudicated claims, and data migration. By reducing costs, boosting productivity, and accelerating revenue cycles, Olive enables hospitals and providers to focus more on patient care while improving financial performance across their operations.

    What Is Olive and What Does It Do?

    Olive, founded in 2012 by Sean Lane and Brad Mascho, is a Columbus-based (United States) healthcare IT company specializing in AI-powered administrative solutions.

    Olive employs 628 people and automates critical administrative processes for healthcare systems, including claims processing, eligibility verification, code matching, and data migration. 

    Olive’s mission is to eliminate manual administrative burdens, reduce operational risk, and streamline cost-heavy workflows using AI and machine learning.

    How Much Funding Has Olive Raised?

    1. Series H
      Amount Raised: $400M
      Date: July 2021
      Lead Investors: Vista Equity Partners, Base10 Partners, Tiger Global Management
      Motivation: To expand Olive’s AI workforce, accelerate enterprise-scale automation tools, and deepen integrations across U.S. healthcare systems.
    2. Series G
      Amount Raised: $226M
      Date: December 2020
      Lead Investors: Tiger Global Management, General Catalyst, Drive Capital, SVB, Google Ventures, Dragoneer Investment Group, Transformation Capital, Sequoia Capital
      Motivation: To enhance AI infrastructure, expand customer adoption, and scale operational performance across major hospital networks.
    3. Series F
      Amount Raised: $106M
      Date: September 2020
      Lead Investors: General Catalyst, Drive Capital, Oak HC/FT, Ascension Ventures, SVB Capital
      Motivation: To grow Olive’s automation capabilities and support national expansion during peak healthcare system demand.

    Total Funding Raised: $902 Million

    Current Valuation: $4 Billion (as of July 2021)

    Latest Funding Date: July 2021

    Key Investors

    1. Tiger Global Management
      Details: Global investment firm backing category-leading tech and healthcare companies.
      Investment Focus Areas: AI, SaaS, healthcare tech, digital infrastructure.
      Notable Investments: Olive, Stripe, DataBricks.
    2. Dragoneer Investment Group
      Details: Long-term investor specializing in high-growth private and public technology companies.
      Investment Focus Areas: Enterprise software, fintech, and AI automation.
      Notable Investments: Airbnb, DoorDash, Snowflake.
    3. General Catalyst
      Details: Leading venture capital firm backing transformative companies across sectors.
      Investment Focus Areas: Healthcare IT, AI automation, enterprise platforms.
      Notable Investments: Olive, Stripe, Samsara.

    Where Is Olive’s Headquarters?

    Olive is headquartered in Columbus, Ohio, a growing hub for healthcare and technology. The location provides Olive with access to major hospital systems, clinical data networks, and a robust midwestern tech talent pipeline, supporting company growth across healthcare automation sectors.

    What’s Next for Olive?

    Olive is expected to expand its AI automation suite by introducing predictive analytics, autonomous claims routing, and end-to-end administrative orchestration for hospitals. The company aims to reduce healthcare operational costs by billions annually. 

    Get Investor & Funding Insights with TexAu 

    TexAu helps sales and business teams uncover detailed fundraising information on companies like Olive. Use the platform to research investors, track funding rounds, and gather actionable insights to strengthen prospecting and business strategy.

    Sign Up for Free on TexAu and start uncovering detailed funding insights that give your business a competitive edge.

    Start your 14-day free trial today, no card needed

    TexAu updates, tips and blogs delivered straight to your inbox.